ENA Respiratory
PrivateLast Round
Series B
Oct 22, 2025
Total Funding Raised
$46.83M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ENA Respiratory is a clinical-stage pharmaceutical company developing antiviral host defence enhancers to combat respiratory viral infections by boosting the body's local innate immune response.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ENA Respiratory Comparables
Compare ENA Respiratory with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NorthLinks Bio | 85% | |
| Leyden Labs | 79% | |
| SaNOtize Research & Development Corp. | 77% | |
ENA Respiratory Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 22, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Grant | Aug 29, 2023 | ||||
| Grant | Jan 9, 2023 | ||||
| VC Round | Jun 15, 2021 | ||||
Series A Extension | Sep 28, 2020 |
Key People
Founding team and executive leadership
ENA Respiratory Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flu Lab | Series B |
| Minderoo Foundation | VC Round |
| United States Department of Defense | Grant |
| Hostplus Superannuation Fund | Series A Extension |
| Bill & Melinda Gates Foundation | Series B |
| Uniseed | Series A, Series A Extension, Series B, VC Round |
| Stoic Venture Capital | Series A Extension, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 41% MoM.
- Jun 1, 2025
Monthly visitors grew 100% MoM, reaching 1.6K.
ENA Respiratory Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ENA Respiratory's valuation, stock price, and market status.